353 related articles for article (PubMed ID: 19767787)
1. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
[TBL] [Abstract][Full Text] [Related]
2. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA
J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
5. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
Laskin BL; Goebel J; Davies SM; Khoury JC; Bleesing JJ; Mehta PA; Filipovich AH; Paff ZN; Lawrence JM; Yin HJ; Pinkard SL; Jodele S
Bone Marrow Transplant; 2011 May; 46(5):682-9. PubMed ID: 20697372
[TBL] [Abstract][Full Text] [Related]
6. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim Y; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2008 May; 41(9):813-20. PubMed ID: 18209725
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
[No Abstract] [Full Text] [Related]
9. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
10. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.
Mii A; Shimizu A; Masuda Y; Fujino T; Kaneko T; Utsumi K; Arai T; Ishikawa A; Wakamatsu K; Tajika K; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Jan; 61(1):34-41. PubMed ID: 21166941
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
[TBL] [Abstract][Full Text] [Related]
12. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy in transplantation and malignancy.
Qu L; Kiss JE
Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?
Llamas P; Romero R; Cabrera R; Sanjuán I; Forés R; Fernández MN
Bone Marrow Transplant; 1997 Aug; 20(4):305-6. PubMed ID: 9285545
[TBL] [Abstract][Full Text] [Related]
16. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
17. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
[TBL] [Abstract][Full Text] [Related]
18. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
[TBL] [Abstract][Full Text] [Related]
20. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]